Tofflon pioneers core life science technology, delivering total solutions and premium products for Cell & Gene therapy, bio-processing, Single-Use technology,bio-separation,cell culture and micro bio-fermentation. We support the entire drug lifecycle, fostering life science advancement for a better world.
Tofflon pioneers core life science technology, delivering total solutions and premium products for Cell & Gene therapy, bio-processing, Single-Use technology,bio-separation,cell culture and micro bio-fermentation. We support the entire drug lifecycle, fostering life science advancement for a better world.
One-stop verification document service
Tofflon can provide the whole bio-process equipments and integrated system from media preparation
Tofflon All-in-one Liquid Mixing System are designed for easy and efficient mixing of buffers, media, intermediates and products, and other process fluids.
Integrated Solution for mAb Manufacturing Platform
Dongfulong Technology Group Co., Ltd. is committed to the pharmaceutical factory pharmaceutical engineering …
Dongfulong Technology Group Co., Ltd. is committed to the pharmaceutical factory pharmaceutical engineering …
Dongfulong Technology Group Co., Ltd. is committed to the pharmaceutical factory pharmaceutical engineering …
Tofflon Technology Group Co., Ltd. is committed to the pharmaceutical factory pharmaceutical engineering …
Dongfulong Technology Group Co., Ltd. is commiTechnologTechnology Group Co., Ltd. is commiy Group Co., Ltd. is commiTechnology Group Co., Ltd. is comm
Learn moreDongfulong Technology Group Co., Ltd. is committed to the pharmaceutical factory pharmaceutical engineering one-stop service. Help pharmaceutical comp
Learn moreDongfulong Technology Group Co., Ltd. is committed to the pharmaceutical factory pharmaceutical engineering one-stop service. Help pharmaceutical comp
Learn moreOn July 28, 2023, in Beijing, China, Sinovac Biotech Ltd. ("SINOVAC"), a leading provider of biopharmaceutical products in China, announced a strategic partnership with Indonesian state-owned company PT Bio Farma. The signing took place on July 27 during the Indonesia-China Healthcare and Biotech Investment Forum in Ch